Navigation Links
OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma
Date:2/28/2012

SAN DIEGO, Feb. 28, 2012 /PRNewswire/ -- OncoSec Medical Incorporated (OTCBB: ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, today announced that Investigational Review Board (IRB) approval has been received by the University of California San Francisco and the first patient has been dosed for a Phase II clinical trial evaluating OncoSec's OMS ElectroImmunotherapy for the treatment of advanced stage cutaneous and in-transit metastatic melanoma. UCSF investigators are actively recruiting for this clinical trial.

(Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO)

"Results from our open-label Phase I study demonstrated that DNA IL-12 and electroporation has the potential to establish a new standard of care for the treatment of late-stage metastatic melanoma," said Punit Dhillon, President and CEO of OncoSec. "With immune response results from this Phase II study expected in the second half of 2012, we are confident this study will validate the value of OMS ElectoImmunotherapy."

A total of up to 25 patients with stage III or IV cutaneous and in-transit metastatic melanoma will be enrolled in this Phase II, single-arm, open-label and multi-center study. The trial is designed to assess local and distant objective response following treatment of cutaneous melanoma lesions with DNA IL-12 and electroporation with a primary endpoint of 24 weeks. One treatment cycle will consist of three treatments applied to up to four lesions on days 1, 5 and 8 with a maximum dose of 1.5 mg DNA IL-12 per treatment cycle. At 12 months, patients will be moved to the follow-up phase of the study and will be followed for up to five years for safety.

OMS ElectroImmunotherapy utilizes OncoSec's proprietary
'/>"/>

SOURCE OncoSec Medical Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. OncoSec to Present at World Cancer Immunotherapy Conference
2. OncoSec to Present at the 22nd Annual Oppenheimer Healthcare Conference
3. OncoSec to Present at 15th Annual Biotech and Specialty Pharmaceuticals Conference
4. OncoSec and Serametrix Collaborate to Identify Potential Biomarkers to Enhance Skin Cancer Immune Therapies
5. OncoSec to Present at Medical Device Investor Forum
6. Device Master File for OncoSec Medical System Completed and Submitted to FDA
7. OncoSec Releases Devices for Use in Clinical Trials
8. Update: OncoSec Announces Positive Results From Head & Neck and Breast Cancer Trials
9. OncoSec Announces Positive Results from Head & Neck and Breast Cancer Trials
10. OncoSec Medical to Attend 6th Annual Fire, Ice and Beyond: The Future of Ablation Therapies Conference
11. OncoSec Medical to Present at Industry and Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... , April 17, 2015 Nonin Medical, ... that President and Chief Operating Officer Steve Bucholz ... Isaacson is expanding his role as Chief Executive ... role as Chief Technology Officer. Operations will transition to ... " Steve Bucholz has been instrumental to Nonin ...
(Date:4/17/2015)... WOONSOCKET, R.I , April 17, 2015 ... holding a conference call on Friday, May 1, 2015, ... discuss its first quarter financial results. An ... simultaneously through the Investor Relations portion of the CVS ... webcast, visit http://investors.cvshealth.com . This webcast will be ...
(Date:4/17/2015)... ASSESS shows   plasma circulating ... viable alternative to tumour biopsy   IGNITE ... advanced NSCLC   AstraZeneca today presented results from ... DNA (ctDNA) testing for epidermal growth factor receptor (EGFR) mutation ... cancer (NSCLC) in clinical practice. [ 1 ] ...
Breaking Medicine Technology:Nonin Medical's Philip Isaacson Expands CEO Role; President and COO Steve Bucholz to Retire May 1 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 4
... Makes Rapid Recovery after Procedure Utilizing IlluminOss(TM) Photodynamic ... Medical today announced that one of the leading ... performed the first case in the world utilizing ... orthopedic surgery. The IlluminOss Photodynamic Bone Stabilization ...
... Feb. 24 BioTrends is pleased to announce the fielding of ... (R) . Takeda Pharmaceutical Company Limited announced that they ... febuxostat) on February 13, 2009. Uloric (R) ... and represents the first product for gout that has been approved ...
Cached Medicine Technology:IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile 2IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile 3
(Date:4/18/2015)... Carinsurancehints.com has released a new blog post explaining how to ... against fire damage. , Clients can now find auto ... is set intentionally on fire. This type of damages can ... things. , It is possible to compare the best ... , in just a few minutes. Clients should always ...
(Date:4/18/2015)... Insuranceautoquote.info has released a new blog post explaining ... , Clients can review important auto insurance quotes ... provides important advantages for clients who need affordable financial ... not have coverage for their vehicles can purchase a ... hour. Many agencies offer important discounts and drivers can ...
(Date:4/18/2015)... 18, 2015 Thousand of DePuy Pinnacle ... of individuals who were allegedly harmed by a metal-on-metal ... forward in the U.S. District Court, Northern District of ... Court has amended an earlier Case Management Order to ... things, the new amendment permits the claims of up ...
(Date:4/18/2015)... April 18, 2015 Aureus Medical ... staffing, including physical therapy jobs, has announced that ... South Carolina Physical Therapy Association Annual Conference to ... Center in Greenville, SC. , The SCAPTA ... exhibits with products and services. , Representatives ...
(Date:4/17/2015)... Heritage Woods of McLeansboro, a Gardant ... Week Celebration on April 20 with a day full ... body and soul. , The community, which is located ... adults of all incomes, including those on Medicaid, who ... Living Week is observed every April and highlights the ...
Breaking Medicine News(10 mins):Health News:Online Auto Insurance Quotes For Plans That Cover Fire Damages! 2Health News:Clients Can Review Car Insurance Quotes Online To Find Low Cost Offers! 2Health News:DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management Order to Allow for Joinder of Unrelated Claims 2Health News:DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management Order to Allow for Joinder of Unrelated Claims 3Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the South Carolina Physical Therapy Association Annual Conference 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3
... EyeSmart(TM) Award to Mr. Abram for 30-year dedication to ... of Rep. Michael E. CapuanoSAN FRANCISCO, April 23 ... is presenting its first EyeSmart(TM) Distinguished Service ... series This Old House and host of ...
... and how does speciation the evolutionary process that results in ... Darwin,s ideas contributed to our understanding of speciation? , Evolutionary biologist ... lecture he will give at UC Riverside at 7 p.m., Thursday, ... , The title of his talk is "The Evolution of Evolution: ...
... NEW YORK, April 23 Donna Tuths, President of ... of the Year" by Med Ad News , ... pharmaceutical industry for 25 years.With 20 years, experience in ... 2003 to focus her consumer marketing expertise on healthcare ...
... benefit manager Prime Therapeutics (Prime) announced today its participation ... Walk. Prime is participating both as a sponsor and ... Blue Cross and Blue Shield Plans. Prime provides pharmacy ... deep commitment to improving the health of members," said ...
... April 23 MAGNET Cooperative, one of the largest non-profit ... sole source agreement with Elekta, enabling its members to begin ... offer its members Elekta,s breakthrough clinical solutions for cancer patient ... Elekta Synergy , an advanced ...
... who received endoscopic procedures at three VA Medical Centers ... According to the Department of Veterans Affairs, the number ... who had colonoscopies at the Murfreesboro, Tennessee, VA Medical ... had colonoscopies at the VAMC in Miami from May ...
Cached Medicine News:Health News:American Academy of Ophthalmology Honors PBS Master Carpenter Norm Abram for His Commitment to Eye Safety 2Health News:American Academy of Ophthalmology Honors PBS Master Carpenter Norm Abram for His Commitment to Eye Safety 3Health News:How new species evolve is focus of public lecture at UC Riverside 2Health News:How new species evolve is focus of public lecture at UC Riverside 3Health News:Donna Tuths Named 2009 Advertising Person of the Year by Med Ad News 2Health News:Donna Tuths Named 2009 Advertising Person of the Year by Med Ad News 3Health News:Elekta Contract Provides MAGNET Cooperative Access to Leading Radiation Therapy Solutions 2Health News:Elekta Contract Provides MAGNET Cooperative Access to Leading Radiation Therapy Solutions 3Health News:Vietnam Veterans of America Calls for Openness and Transparency in Addressing Contaminated Medical Equipment at VAMCs 2
... double spot test is a rapid, ... antibodies to T. cruzi in human ... samples. This test is intended primarily ... reactive samples should be confirmed by ...
... is intended for the immunochromatographic, qualitative ... samples.,Smart Strip Gonorrhea is based on ... the determination of gonorrhea antigen in ... urinary system as an aid in ...
Inquire...
For the rapid determination of human chorionic gonadotropin (hCG) in urine and serum. The test strip is used to obtain a visual qualitative result....
Medicine Products: